Pfizer’s Covid-19 vaccine faces one final hurdle as it races to become the first jab to be cleared for use in the US.
Pfizer’s Covid-19 vaccine faces one final hurdle as it races to become the first jab to be cleared for use in the US. Thursday’s meeting of the Food and Drug Administration’s (FDA) vaccine advisory panel is likely the last step before a US decision to begin shipping millions of doses of the shot, which has shown strong protection against the coronavirus. The FDA panel functions like a science court that will pick apart the data and debate — in public and live-streamed — whether the shot is safe and effective enough to be cleared for emergency use. The non-government experts specialise in vaccine development, infectious diseases and medical statistics. The FDA is expected to follow the committee’s advice, although it is not required to do so. The FDA’s decision comes as the coronavirus continues surging across much of the world, claiming more than 1.
